Interventional Management of Stroke (IMS) III Trial
Status:
Terminated
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two different treatment approaches to recanalization
started within 3 hours of symptom onset-combined intravenous (IV) and endovascular therapy
and standard intravenous (IV) rt-PA alone.
Phase:
Phase 3
Details
Lead Sponsor:
Joseph Broderick
Collaborators:
Medical University of South Carolina National Institute of Neurological Disorders and Stroke (NINDS) University of Calgary